AGP Executive Report
Last update: 44 minutes agoPharma and Supply Chains: Samsung Biologics disclosed a $323 million manufacturing contract, with the client citing the U.S. Biosecure Act; Merck KGaA is selling its CDMO business to Lonza. India also proposed more import gateways for drugs and medical devices. Healthcare Business: CVS Health is reportedly planning to split its pharmacy and insurance businesses in 2028. Blood Pressure Care: Medtronic’s real-world study found significant six-month blood pressure reductions with its renal denervation procedure, without increased use of medication. Safer Antibiotic Use: Nearly one in five patients treated for dental infections received clindamycin, a drug linked to potentially life-threatening C. difficile infection, a study found. Measles Alert: New York state reported its first measles-linked child death in 30 years.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.